ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,665Medicare Part D Prescriptions Filled, Including Refills

Rank: 168 out of 783

$602K Total Retail Price of All Prescriptions

Rank: 198 out of 783

273 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
57% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 273 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

19% of this provider’s 273 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 6,792 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
SIMVASTATIN 361 226 1 3
HYDROCHLOROTHIAZIDE 293 217 2 12
LISINOPRIL 286 185 3 4
HYDROCODONE-ACETAMINOPHEN 271 170 S3 4 2
FUROSEMIDE 263 207 5 7
OMEPRAZOLE 260 169 6 6
AMLODIPINE BESYLATE 258 187 7 5
METFORMIN HCL 222 137 8 8
POTASSIUM CHLORIDE 219 153 9 16
LEVOTHYROXINE SODIUM 210 149 10 1
GABAPENTIN 203 100 11 15
MELOXICAM 195 128 12 37
ZOLPIDEM TARTRATE 167 68 13 23
WARFARIN SODIUM 167 114 13 10
RANITIDINE HCL 167 66 13 44
CITALOPRAM HBR 128 61 16 19
ENALAPRIL MALEATE 119 107 17 68
CARVEDILOL 116 81 18 21
TRAMADOL HCL 113 58 19 20
LOVASTATIN 113 93 19 58
CYMBALTA 112 54 21 35
GLIMEPIRIDE 111 74 22 34
METOPROLOL TARTRATE 105 89 23 9
LISINOPRIL-HYDROCHLOROTHIAZIDE 98 52 24 33
METOPROLOL SUCCINATE 97 72 25 13
ALENDRONATE SODIUM 90 81 26 25
LOSARTAN-HYDROCHLOROTHIAZIDE 89 45 27 53
GLIPIZIDE ER 87 48 28 84
ROPINIROLE HCL 87 43 28 74
CLONIDINE HCL 86 64 30 60
CLOPIDOGREL 83 42 31 29
FENTANYL 81 21 S2 32 65
PREDNISONE 78 47 33 36
LOSARTAN POTASSIUM 77 69 34 18
CYCLOBENZAPRINE HCL 75 15 R 35 63
PRAMIPEXOLE DIHYDROCHLORIDE 74 46 36 147
ATENOLOL 71 53 37 17
SPIRIVA 69 31 38 59
GEMFIBROZIL 68 50 39 105
BYSTOLIC 65 54 40 99
SERTRALINE HCL 65 44 40 22
SINGULAIR 64 33 42 90
ATORVASTATIN CALCIUM 64 37 42 11
ESCITALOPRAM OXALATE 63 34 44 54
PLAVIX 63 32 44 51
NEXIUM 63 51 44 28
ALLOPURINOL 61 37 47 31
DICLOFENAC SODIUM 57 19 48 139
PROAIR HFA 56 19 49 56
THEOPHYLLINE ANHYDROUS 55 55 50 219
FLUOXETINE HCL 53 29 51 45
DIOVAN 53 35 51 49
BACLOFEN 53 24 51 125
METHOTREXATE 53 0 51 158
KLOR-CON 10 51 44 55 102
MORPHINE SULFATE ER 50 0 S2 56 107
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 19, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.